Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge Study

NCT05347693 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

186

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperkalaemia
Chronic Kidney Disease

Interventions

DRUG: Sodium Zirconium Cyclosilicate (SZC)
DRUG: Local standard of care

Sponsor

AstraZeneca